The Straumann Group has purchased a 30% interest in its biomaterials partner Botiss Medical for an undisclosed sum.
Based in Switzerland, Straumann is a replacement and orthodontic solutions provider, while Botiss Medical is a Germany-based provider of biomaterials for implantology and oral surgery.
Go deeper with GlobalData
The transaction enables the acquirer to expand its worldwide distribution network through Botiss’ line of products.
Molnlycke Health Care has completed the acquisition of SastoMed for an undisclosed sum.
Based in Sweden, Molnlycke Health Care is a medical device company that provides wound care products, while SastoMed is also a wound care products provider based in Germany.
The transaction enables the acquirer company to strengthen its position in the active and passive wound healing areas.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataYoung Innovations has completed the acquisition of Johnson-Promident, a US-based producer and retailer of dental hand-pieces and preventive consumables.
The transaction enables the acquirer to support its dealers, institutional partners and dental professionals across the world by delivering high-quality products.
Based in the US, Young Innovations is a medical device company that provides dental products and a portfolio company of The Jordan Company.
Shanghai Kehua Bio-engineering plans to purchase 26.6983% capital in Suzhou Hybiome Biomedical Engineering Co Ltd for CNY336.02m ($50.7m).
Both the companies involved in the transaction are medical device companies based in the US.
Thermo Fisher has signed an agreement to purchase Roper subsidiary Gatan for $925m.
The acquisition is expected to close in the last quarter of 2018, subject to customary closing conditions and other regulatory approvals.
Thermo Fisher is a provider of diagnostic products, while Gatan is a manufacturer of instrumentation and software. Both companies are based in the US.
The acquisition will be a complementary addition to Thermo Fisher’s electron microscopy portfolio and enhances its product offerings.
